Chronic Stroke clinical trials at UC Irvine

• Investigation of Neural Stem Cells in Ischemic Stroke

  open to eligible people ages 35-75

  A study of stereotactic, intracerebral injection of CTX0E03 neural stem cells into patients with moderate to moderately severe disability as a result of an ischemic stroke.

  Irvine, California and other locations

Last updated: February 25, 2020